U.S. health officials warned the public on Friday about the risk of a rare type of muscle injury seen when the cholesterol drug simvastatin is combined with the anti-arrhythmia medicine amiodarone.

• 星期五，美国食品和药品监督局官员提醒公众，降血脂药辛伐他汀和抗心律失常药胺碘酮合用有增加一种少见类型的肌肉损伤风险。